Decision-making on malaria vaccine introduction: the role of cost-effectiveness analysis
Author(s) -
Vasee Moorthy,
Raymond Hutubessy,
Robert D. Newman,
Joachim Hombach
Publication year - 2012
Publication title -
bulletin of the world health organization
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.459
H-Index - 168
eISSN - 1564-0604
pISSN - 0042-9686
DOI - 10.2471/blt.12.107482
Subject(s) - cost effectiveness , malaria , malaria vaccine , equity (law) , cost effectiveness analysis , poverty , public health , cost–benefit analysis , medicine , risk analysis (engineering) , actuarial science , environmental health , business , economic growth , economics , immunology , plasmodium falciparum , political science , nursing , law
As highlighted earlier, cost–effectiveness is only one criterion among many that influence decision-making in public health. When deciding to implement an intervention, efficiency must always be balanced with other criteria, including implementation capacity, feasibility and impact on poverty and equity.14 In the case of RTS,S/AS01, WHO will provide an updated cost–effectiveness assessment in 2015, at the time when decision-making by countries will be necessary. The status of the field of malaria vaccine cost–effectiveness does not yet support the use of simple, national-level vaccine impact or cost–effectiveness tools by country programmes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom